Atlas Trials

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Clinical trial NCT00818298 · COMPLETED

Trial details

NCT number
NCT00818298
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2009-01-01
Primary completion
2011-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.